Mountain Valley MD Holdings Inc.

CNSX:MVMD Stock Report

Market Cap: CA$10.6m

Mountain Valley MD Holdings Past Earnings Performance

Past criteria checks 0/6

Mountain Valley MD Holdings has been growing earnings at an average annual rate of 26.8%, while the Pharmaceuticals industry saw earnings growing at 45.6% annually. Revenues have been growing at an average rate of 11.2% per year.

Key information

26.8%

Earnings growth rate

38.5%

EPS growth rate

Pharmaceuticals Industry Growth23.1%
Revenue growth rate11.2%
Return on equity-87.6%
Net Margin-8,675.0%
Last Earnings Update30 Sep 2024

Recent past performance updates

No updates

Recent updates

We're Not Very Worried About Mountain Valley MD Holdings' (CSE:MVMD) Cash Burn Rate

Jan 09
We're Not Very Worried About Mountain Valley MD Holdings' (CSE:MVMD) Cash Burn Rate

Is Mountain Valley MD Holdings (CSE:MVMD) In A Good Position To Invest In Growth?

Jul 14
Is Mountain Valley MD Holdings (CSE:MVMD) In A Good Position To Invest In Growth?

Revenue & Expenses Breakdown

How Mountain Valley MD Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CNSX:MVMD Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 240-840
30 Jun 240-830
31 Mar 240-830
31 Dec 230-731
30 Sep 230-431
30 Jun 230-631
31 Mar 230-741
31 Dec 220-742
30 Sep 220-962
30 Jun 220-972
31 Mar 220-1072
31 Dec 210-1483
30 Sep 210-1262
30 Jun 210-1042
31 Mar 210-831
31 Dec 200-2030
30 Sep 200-1930
30 Jun 200-1930
31 Mar 200-1930

Quality Earnings: MVMD is currently unprofitable.

Growing Profit Margin: MVMD is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MVMD is unprofitable, but has reduced losses over the past 5 years at a rate of 26.8% per year.

Accelerating Growth: Unable to compare MVMD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MVMD is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-51.1%).


Return on Equity

High ROE: MVMD has a negative Return on Equity (-87.6%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 04:04
End of Day Share Price 2025/01/06 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mountain Valley MD Holdings Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution